Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 28.10x is 92% below its estimated 5-year average of 350.19x, near the low end of its estimated 5-year range (0.20x–15477.27x).
As of 2026-10-06T20:35:54.223Z. 17.96% above its estimated 12-month average of 23.82x.
Calculation as of: 2026-10-06T20:35:54.223Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: efaaa36d31f915a5dffaa91b800fc30e2d7f64892a7236e7a1e7b68ff3f7d584
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
28.10x
EV/SALES RATIO AVG TTM
23.82x
EV/SALES RATIO AVG 3Y
126.20x
EV/SALES RATIO AVG 5Y
350.19x
EV/SALES RATIO AVG 10Y
615.48x
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+17.96%
CURRENT VS 3Y AVG
-77.73%
CURRENT VS 5Y AVG
-91.98%
CURRENT VS 10Y AVG
-95.43%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.37x
median of 548 covered companies
CURRENT VS SECTOR MEDIAN
+543.02%
vs the sector median at left
Crescent Biopharma, Inc.
Market Cap
$504.04M
EV/Sales Ratio
28.10x
TTM Avg
23.82x
3Y Avg
126.20x
5Y Avg
350.19x
Market Cap
$503.93M
EV/Sales Ratio
115.44x
TTM Avg
137.79x
3Y Avg
11402.18x
5Y Avg
6462.77x
Market Cap
$502.81M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$500.52M
EV/Sales Ratio
1.27x
TTM Avg
1.59x
3Y Avg
1.25x
5Y Avg
1.40x
Market Cap
$498.52M
EV/Sales Ratio
1644.30x
TTM Avg
1857.31x
3Y Avg
1997.04x
5Y Avg
1831.19x
Market Cap
$516.76M
EV/Sales Ratio
60.54x
TTM Avg
53.58x
3Y Avg
21.24x
5Y Avg
46.54x
Market Cap
$519.25M
EV/Sales Ratio
15869.08x
TTM Avg
12786.98x
3Y Avg
8694.17x
5Y Avg
5938.95x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Crescent Biopharma, Inc. (CBIO) | $504.04M | 28.10x | 23.82x | 126.20x | 350.19x |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.93M | 115.44x | 137.79x | 11402.18x | 6462.77x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $502.81M | N/A | N/A | N/A | N/A |
| 908 Devices Inc. (MASS)vs › | $505.87M | 7.35x | 3.81x | 2.66x | 4.57x |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.52M | 1.27x | 1.59x | 1.25x | 1.40x |
| Oculis Holding AG (OCS)vs › | $498.52M | 1644.30x | 1857.31x | 1997.04x | 1831.19x |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $516.76M | 60.54x | 53.58x | 21.24x | 46.54x |
| Altimmune, Inc. (ALT)vs › | $519.25M | 15869.08x | 12786.98x | 8694.17x | 5938.95x |
| Evolus, Inc. (EOLS)vs › | $486.01M | 1.91x | 1.75x | 2.81x | 3.25x |
| Immix Biopharma, Inc. (IMMX)vs › | $524.43M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 21.50x |
| 2026-10-02 | 22.47x |
| 2026-10-01 | 22.32x |
| 2026-09-30 | 23.17x |
| 2026-09-29 | 23.61x |
| 2026-09-28 | 23.01x |
| 2026-09-25 | 21.63x |
| 2026-09-24 | 22.27x |
| 2026-09-23 | 22.14x |
| 2026-09-22 | 27.92x |
| 2026-09-21 | 27.43x |
| 2026-09-18 | 29.08x |
| 2026-09-17 | 28.77x |
| 2026-09-16 | 29.82x |
| 2026-09-15 | 33.99x |
| 2026-09-14 | 36.25x |
| 2026-09-11 | 35.55x |
| 2026-09-10 | 35.68x |
| 2026-09-09 | 37.04x |
| 2026-09-08 | 38.25x |
| 2026-09-04 | 39.33x |
| 2026-09-03 | 38.10x |
| 2026-09-02 | 33.32x |
| 2026-09-01 | 31.75x |
| 2026-08-31 | 28.33x |
| 2026-08-28 | 31.29x |
| 2026-08-27 | 31.31x |
| 2026-08-26 | 31.98x |
| 2026-08-25 | 29.36x |
| 2026-08-24 | 29.28x |
| 2026-08-21 | 29.75x |
| 2026-08-20 | 27.38x |
| 2026-08-19 | 30.18x |
| 2026-08-18 | 28.56x |
| 2026-08-17 | 30.59x |
| 2026-08-14 | 29.72x |
| 2026-08-13 | 28.41x |
| 2026-08-12 | 27.90x |
| 2026-08-11 | 28.56x |
| 2026-08-10 | 30.21x |
| 2026-08-07 | 28.95x |
| 2026-08-06 | 27.90x |
| 2026-08-05 | 26.20x |
| 2026-08-04 | 27.77x |
| 2026-08-03 | 23.89x |
| 2026-07-31 | 22.86x |
| 2026-07-30 | 22.63x |
| 2026-07-29 | 21.99x |
| 2026-07-28 | 26.27x |
| 2026-07-27 | 27.52x |
| 2026-07-24 | 25.91x |
| 2026-07-23 | 27.78x |
| 2026-07-22 | 24.71x |
| 2026-07-21 | 26.78x |
| 2026-07-20 | 22.71x |
| 2026-07-17 | 21.94x |
| 2026-07-16 | 22.86x |
| 2026-07-15 | 24.30x |
| 2026-07-14 | 23.38x |
| 2026-07-13 | 24.35x |
| 2026-07-10 | 28.57x |
| 2026-07-09 | 27.08x |
| 2026-07-08 | 27.21x |
| 2026-07-07 | 27.78x |
| 2026-07-06 | 27.60x |
| 2026-07-02 | 27.93x |
| 2026-07-01 | 27.90x |
| 2026-06-30 | 30.26x |
| 2026-06-29 | 30.26x |
| 2026-06-26 | 31.69x |
| 2026-06-25 | 27.67x |
| 2026-06-24 | 28.62x |
| 2026-06-23 | 28.98x |
| 2026-06-22 | 29.16x |
| 2026-06-18 | 29.46x |
| 2026-06-17 | 30.79x |
| 2026-06-16 | 30.13x |
| 2026-06-15 | 30.74x |
| 2026-06-12 | 30.05x |
| 2026-06-11 | 31.13x |
| 2026-06-10 | 29.16x |
| 2026-06-09 | 30.26x |
| 2026-06-08 | 28.42x |
| 2026-06-05 | 30.26x |
| 2026-06-04 | 31.41x |
| 2026-06-03 | 30.21x |
| 2026-06-02 | 27.72x |
| 2026-06-01 | 34.66x |
| 2026-05-29 | 37.04x |
| 2026-05-28 | 39.13x |
| 2026-05-27 | 37.39x |
| 2026-05-26 | 36.27x |
| 2026-05-22 | 37.27x |
| 2026-05-21 | 35.96x |
| 2026-05-20 | 32.58x |
| 2026-05-19 | 31.48x |
| 2026-05-18 | 31.66x |
| 2026-05-15 | 35.30x |
| 2026-05-14 | 38.52x |
| 2026-05-13 | 34.38x |
| 2026-05-12 | 31.43x |
| 2026-05-11 | 31.59x |
| 2026-05-08 | 15.39x |
| 2026-05-07 | 13.97x |
| 2026-05-06 | 14.08x |
| 2026-05-05 | 14.12x |
| 2026-05-04 | 13.82x |
| 2026-05-01 | 14.10x |
| 2026-04-30 | 22.10x |
| 2026-04-29 | 19.44x |
| 2026-04-28 | 25.06x |
| 2026-04-27 | 27.27x |
| 2026-04-24 | 26.62x |
| 2026-04-23 | 28.30x |
| 2026-04-22 | 30.68x |
| 2026-04-21 | 26.19x |
| 2026-04-20 | 20.84x |
| 2026-04-17 | 20.07x |
| 2026-04-16 | 16.67x |
| 2026-04-15 | 17.60x |
| 2026-04-14 | 16.80x |
| 2026-04-13 | 13.95x |
| 2026-04-10 | 14.29x |
| 2026-04-09 | 16.02x |
| 2026-04-08 | 14.57x |
| 2026-04-07 | 16.22x |
| 2026-04-06 | 16.54x |
| 2026-04-02 | 16.58x |
| 2026-04-01 | 16.43x |
| 2026-03-31 | 14.66x |
| 2026-03-30 | 11.41x |
| 2026-03-27 | 8.69x |
| 2026-03-26 | 5.60x |
| 2026-03-25 | 2.40x |
| 2026-03-23 | 1.03x |
| 2026-03-20 | 0.77x |
| 2026-03-19 | 0.25x |
| 2026-03-17 | 1.14x |
| 2026-03-16 | 2.03x |
| 2026-03-13 | 1.29x |
| 2026-03-12 | 1.99x |
| 2026-03-11 | 2.59x |
| 2026-03-10 | 3.84x |
| 2026-03-09 | 2.85x |
| 2026-03-06 | 2.94x |
| 2026-03-05 | 1.57x |
| 2026-03-04 | 1.86x |
| 2026-03-03 | 1.31x |
| 2026-03-02 | 1.32x |
| 2026-02-27 | 2.98x |
| 2025-02-13 | 417.10x |
| 2025-02-12 | 262.34x |
| 2025-02-11 | 366.80x |
| 2025-02-10 | 268.14x |
| 2025-02-07 | 296.52x |
| 2025-02-06 | 340.36x |
| 2025-02-05 | 386.15x |
| 2025-02-04 | 334.56x |
| 2025-02-03 | 276.53x |
| 2025-01-31 | 316.51x |
| 2025-01-30 | 441.60x |
| 2025-01-29 | 215.91x |
| 2025-01-28 | 213.33x |
| 2025-01-27 | 253.96x |
| 2025-01-24 | 342.94x |
| 2025-01-23 | 326.82x |
| 2025-01-22 | 244.28x |
| 2025-01-21 | 282.33x |
| 2025-01-17 | 263.63x |
| 2025-01-16 | 213.33x |
| 2025-01-15 | 222.36x |
| 2025-01-14 | 206.24x |
| 2025-01-13 | 204.95x |
| 2025-01-10 | 295.87x |
| 2025-01-08 | 371.96x |
| 2025-01-07 | 419.03x |
| 2025-01-06 | 418.39x |
| 2025-01-03 | 373.25x |
| 2025-01-02 | 233.32x |
| 2024-12-31 | 192.70x |
| 2024-12-30 | 190.76x |
| 2024-12-27 | 111.45x |
| 2024-12-26 | 233.97x |
| 2024-12-24 | 147.56x |
| 2024-12-20 | 95.33x |
| 2024-12-18 | 17.94x |
| 2024-12-17 | 90.17x |
| 2024-12-16 | 134.02x |
| 2024-12-13 | 126.92x |
| 2024-12-12 | 177.86x |
| 2024-12-11 | 395.18x |
| 2024-12-10 | 475.78x |
| 2024-12-09 | 534.46x |
| 2024-12-06 | 486.10x |
| 2024-12-05 | 428.06x |
| 2024-12-04 | 528.01x |
| 2024-12-03 | 585.40x |
| 2024-12-02 | 711.15x |
| 2024-11-29 | 823.99x |
| 2024-11-27 | 606.04x |
| 2024-11-26 | 656.98x |
| 2024-11-25 | 439.02x |
| 2024-11-22 | 629.90x |
| 2024-11-21 | 650.53x |
| 2024-11-20 | 715.02x |
| 2024-11-19 | 1031.63x |
| 2024-11-18 | 1264.42x |
| 2024-11-15 | 1269.58x |
| 2024-11-14 | 1162.53x |
| 2024-11-13 | 398.52x |
| 2024-11-12 | 356.61x |
| 2024-11-11 | 499.12x |
| 2024-11-08 | 465.58x |
| 2024-11-07 | 515.24x |
| 2024-11-06 | 234.09x |
| 2024-11-05 | 321.14x |
| 2024-11-04 | 450.11x |
| 2024-11-01 | 273.42x |
| 2024-10-31 | 430.12x |
| 2024-10-30 | 749.96x |
| 2024-10-29 | 965.98x |
| 2024-05-03 | 7685.62x |
| 2024-05-02 | 6977.29x |
| 2024-05-01 | 6333.35x |
| 2024-04-30 | 7492.44x |
| 2024-04-29 | 5882.60x |
| 2024-04-26 | 6462.14x |
| 2024-04-25 | 6912.90x |
| 2024-04-24 | 7878.80x |
| 2024-04-23 | 7750.02x |
| 2024-04-22 | 7492.44x |
| 2024-04-19 | 8329.56x |
| 2024-04-18 | 9810.62x |
| 2024-04-17 | 10583.34x |
| 2024-04-16 | 9746.22x |
| 2024-04-15 | 10454.56x |
| 2024-04-12 | 11356.07x |
| 2024-04-11 | 12064.40x |
| 2024-04-10 | 11678.04x |
| 2024-04-09 | 13159.10x |
| 2024-04-08 | 12579.55x |
| 2024-04-05 | 13609.85x |
| 2024-04-04 | 13352.28x |
| 2024-04-03 | 13738.64x |
| 2024-04-02 | 14962.12x |
| 2024-04-01 | 15477.27x |
| 2024-03-28 | 15219.70x |
| 2023-08-02 | 421.41x |
| 2023-08-01 | 469.69x |
| 2023-07-31 | 461.65x |
| 2023-07-28 | 461.65x |
| 2023-07-27 | 437.51x |
| 2023-07-26 | 429.46x |
| 2023-07-25 | 445.55x |
| 2023-07-24 | 461.65x |
| 2023-07-21 | 477.74x |
| 2023-07-20 | 461.65x |
| 2023-07-19 | 429.46x |
| 2023-07-18 | 517.97x |
| 2023-07-17 | 501.88x |
Showing the most recent 260 of 1,578 data points. The chart above shows the full history.
